Reduction of Corticostriatal Glutamatergic Fibers in Basic Fibroblast Growth Factor Deficient Mice is Associated with Hyperactivity and Enhanced Dopaminergic Transmission

Biological Psychiatry

Volumn 62, Issue 3, 2007, Pages 235-242

  Fadda, Paola ^a   Bedogni, Francesco ^b   Fresu, Alessandra ^a   Collu, Maria ^a   Racagni, Giorgio ^b,c   Riva, Marco A ^b  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

Author keywords

Animal model; cocaine; fibroblast growth factor; knockout; prefrontal cortex; schizophrenia

Indexed keywords

AMPHETAMINE; APOMORPHINE; BASIC FIBROBLAST GROWTH FACTOR; COCAINE; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; EXCITATORY AMINO ACID TRANSPORTER 3; PRESYNAPTIC RECEPTOR; VESICULAR GLUTAMATE TRANSPORTER 1;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; DOPAMINERGIC TRANSMISSION; HYPERACTIVITY; LOCOMOTION; MOUSE; MOUSE STRAIN; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; STRIATE CORTEX;

ACTINS; ANALYSIS OF VARIANCE; ANIMALS; APOMORPHINE; COCAINE; DEXTROAMPHETAMINE; DOPAMINE; DOPAMINE AGENTS; EXCITATORY AMINO ACID TRANSPORTER 3; EXPLORATORY BEHAVIOR; FIBROBLAST GROWTH FACTOR 2; FRONTAL LOBE; GLUTAMIC ACID; HYPERKINESIS; MICE; MICE, KNOCKOUT; MOTOR ACTIVITY; NEOSTRIATUM; NERVE FIBERS; NEURAL PATHWAYS; PRESYNAPTIC TERMINALS; RNA, MESSENGER; SYNAPTIC TRANSMISSION; VESICULAR GLUTAMATE TRANSPORT PROTEIN 1;

EID: 34447298369     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2006.08.003     Document Type: Article

References (36)

1. Anderson K.J., Dam D., Lee S., and Cotman C.W. Basic fibroblast growth factor prevents death of lesioned cholinergic neurons in vivo. Nature 332 (1988) 360-361
2. Carlsson A., Waters N., Holm-Waters S., Tedroff J., Nilsson M., and Carlsson M.L. Interactions between monoamines, glutamate, and GABA in schizophrenia: New evidence. Annu Rev Pharmacol Toxicol 41 (2001) 237-260
3. Dono R., Texido G., Dussel R., Ehmke H., and Zeller R. Impaired cerebral cortex development and blood pressure regulation in FGF-2-deficient mice. EMBO J 17 (1998) 4213-4225
4. Eastwood S.L., and Harrison P.J. Decreased expression of vesicular glutamate transporter 1 and complexin II mRNAs in schizophrenia: Further evidence for a synaptic pathology affecting glutamate neurons. Schizophr Res 73 (2005) 159-172
5. Ernfors P., Lonnerberg P., Ayer-LeLievre C., and Persson H. Developmental and regional expression of basic fibroblast growth factor mRNA in the rat central nervous system. J Neurosci Res 27 (1990) 10-15
6. Evans S.J., Choudary P.V., Neal C.R., Li J.Z., Vawter M.P., Tomita H., et al. Dysregulation of the fibroblast growth factor system in major depression. Proc Natl Acad Sci U S A 101 (2004) 15506-15511
7. Flores C., Rodaros D., and Stewart J. Long-lasting induction of astrocytic basic fibroblast growth factor by repeated injections of amphetamine: Blockade by concurrent treatment with a glutamate antagonist. J Neurosci 18 (1998) 9547-9555
8. Flores C., Samaha A.N., and Stewart J. Requirement of endogenous basic fibroblast growth factor for sensitization to amphetamine. J Neurosci 20 (2000) RC55
9. Fremeau Jr. R.T., Voglmaier S., Seal R.P., and Edwards R.H. VGLUTs define subsets of excitatory neurons and suggest novel roles for glutamate. Trends Neurosci 27 (2004) 98-103
10. Fumagalli F., Molteni R., Calabrese F., Frasca A., Racagni G., and Riva M.A. Chronic fluoxetine administration inhibits extracellular signal-regulated kinase 1/2 phosphorylation in rat brain. J Neurochem 93 (2005) 1551-1560
11. Ghosh A., and Greenberg M.E. Distinct roles for bFGF and NT-3 in the regulation of cortical neurogenesis. Neuron 15 (1995) 89-103
12. Harrison P.J., and Weinberger D.R. Schizophrenia genes, gene expression, and neuropathology: On the matter of their convergence. Mol Psychiatry 10 (2005) 40-68 image 5.
13. Hyman S.E. Addiction: A disease of learning and memory. Am J Psychiatry 162 (2005) 1414-1422
14. Jones S.R., Gainetdinov R.R., Wightman R.M., and Caron M.G. Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. J Neurosci 18 (1998) 1979-1986
15. Kalivas P.W. Glutamate systems in cocaine addiction. Curr Opin Pharmacol 4 (2004) 23-29
16. Kalivas P.W., and Volkow N.D. The neural basis of addiction: A pathology of motivation and choice. Am J Psychiatry 162 (2005) 1403-1413
17. Kiprianova I., Schindowski K., von Bohlen und Halbach O., Krause S., Dono R., Schwaninger M., et al. Enlarged infarct volume and loss of BDNF mRNA induction following brain ischemia in mice lacking FGF-2. Exp Neurol 189 (2004) 252-260
18. Klejbor I., Myers J.M., Hausknecht K., Corso T.D., Gambino A.S., Morys J., et al. Fibroblast growth factor receptor signaling affects development and function of dopamine neurons-inhibition results in a schizophrenia-like syndrome in transgenic mice. J Neurochem 97 (2006) 1243-1258
19. Korada S., Zheng W., Basilico C., Schwartz M.L., and Vaccarino F.M. Fibroblast growth factor 2 is necessary for the growth of glutamate projection neurons in the anterior neocortex. J Neurosci 22 (2002) 863-875
20. Laruelle M., Kegeles L.S., and Abi-Dargham A. Glutamate, dopamine, and schizophrenia: From pathophysiology to treatment. Ann N Y Acad Sci 1003 (2003) 138-158
21. Lewis D.A., Glantz L.A., Pierri J.N., and Sweet R.A. Altered cortical glutamate neurotransmission in schizophrenia: Evidence from morphological studies of pyramidal neurons. Ann N Y Acad Sci 1003 (2003) 102-112
22. Ornitz D.M. FGFs, heparan sulfate and FGFRs: Complex interactions essential for development. Bioessays 22 (2000) 108-112
23. Ortega S., Ittmann M., Tsang S.H., Ehrlich M., and Basilico C. Neuronal defects and delayed wound healing in mice lacking fibroblast growth factor 2. Proc Natl Acad Sci U S A 95 (1998) 5672-5677
24. Otto D., and Unsicker K. Basic FGF reverses chemical and morphological deficits in the nigrostriatal system of MPTP-treated mice. J Neurosci 10 (1990) 1912-1921
25. Raballo R., Rhee J., Lyn-Cook R., Leckman J.F., Schwartz M.L., and Vaccarino F.M. Basic fibroblast growth factor (Fgf2) is necessary for cell proliferation and neurogenesis in the developing cerebral cortex. J Neurosci 20 (2000) 5012-5023
26. Reuss B., and von Bohlen und Halbach O. Fibroblast growth factors and their receptors in the central nervous system. Cell Tissue Res 313 (2003) 139-157
27. Riva M.A., Molteni R., Bedogni F., Racagni G., and Fumagalli F. Emerging role of the FGF system in psychiatric disorders. Trends Pharmacol Sci 26 (2005) 228-231
28. Riva M.A., Molteni R., Lovati E., Fumagalli F., Rusnati M., and Racagni G. Cyclic AMP-dependent regulation of fibroblast growth factor-2 messenger RNA levels in rat cortical astrocytes: Comparison with fibroblast growth factor-1 and ciliary neurotrophic factor. Mol Pharmacol 49 (1996) 699-706
29. Shigeri Y., Seal R.P., and Shimamoto K. Molecular pharmacology of glutamate transporters, EAATs and VGLUTs. Brain Res Brain Res Rev 45 (2004) 250-265
30. Shin D.M., Korada S., Raballo R., Shashikant C.S., Simeone A., Taylor J.R., et al. Loss of glutamatergic pyramidal neurons in frontal and temporal cortex resulting from attenuation of FGFR1 signaling is associated with spontaneous hyperactivity in mice. J Neurosci 24 (2004) 2247-2258
31. Vaccarino F.M., Schwartz M.L., Raballo R., Nilsen J., Rhee J., Zhou M., et al. Changes in cerebral cortex size are governed by fibroblast growth factor during embryogenesis. Nat Neurosci 2 (1999) 848
32. Van Hartesveldt C. Temporal and environmental effects on quinpirole-induced biphasic locomotion in rats. Pharmacol Biochem Behav 58 (1997) 955-960
33. West A.R., Floresco S.B., Charara A., Rosenkranz J.A., and Grace A.A. Electrophysiological interactions between striatal glutamatergic and dopaminergic systems. Ann N Y Acad Sci 1003 (2003) 53-74
34. Wilson S.J., Sayette M.A., and Fiez J.A. Prefrontal responses to drug cues: A neurocognitive analysis. Nat Neurosci 7 (2004) 211-214
35. Winterer G., and Weinberger D.R. Genes, dopamine and cortical signal-to-noise ratio in schizophrenia. Trends Neurosci 27 (2004) 683-690
36. Zhou M., Sutliff R.L., Paul R.J., Lorenz J.N., Hoying J.B., Haudenschild C.C., et al. Fibroblast growth factor 2 control of vascular tone. Nat Med 4 (1998) 201-207